Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

MDD review: Orthopedic implants are included among devices that should be upclassified as part of the EU Medical Devices Directive review in MEP Minerva Malliori's 1report on health implications of the MDD. During discussions in the EP's ENVI committee March 18, the European Parliamentarian also suggested that the directive encourage member states to take additional device reuse precautions, ease clinical data availability for manufacturers, tighten postmarket surveillance and improve notified body monitoring. ENVI is scheduled to vote on the report April 22, with plenary approval expected in May. Manufacturers are lobbying against the orthopedic reclassification (2"The Gray Sheet" March 3, 2003, p. 11)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel